Differences in Hemoglobin Glycation Rate in Diabete Mellitus Patients
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 入组人数
- 25
- 主要终点
- Primary endpoint is to see whether they are fast glycators
研究概览
简要总结
HbA1c is used as a gold standard to see whether patients have optimal glycemic control. Today, many physicians rely solely on HbA1c to change medication. However, there is a select group of patients that have low average glucose levels but high HbA1c levels. The investigators believe that these patients are fast glycators meaning that they incorporate sugar into their hemoglobin faster than normal. The investigators want to determine whether these patients are fast glycators.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 25 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient with diabetes
- •Patients who test their sugar levels at least 3 times daily
- •Recorded diary of sugar levels for the past month
- •Willingness to have blood drawn
- •Willingness to allow their blood sugar diary to be photocopied
- •Estimated average glucose as derived from A1c is ≥ 4 mmol from measured glucose from self-monitoring blood glucose testing
排除标准
- •Patient with medical conditions that may affect their study participation or results will be excluded.
- •Patients who are anemic
- •Renal insufficient with a serum creatinine level > 200 μmol/L
研究组 & 干预措施
Fast Glycator
The subjects enrolled in this study will have a fructosamine test and blood drawn to see whether they are fast glycators
干预措施: Fast Glycator (Other)
Control
These patients will have their blood drawn to know what the normal glycation rate is in diabetic patients
干预措施: Control (Other)
结局指标
主要结局
Primary endpoint is to see whether they are fast glycators
时间窗: One Week
次要结局
- A secondary endpoint includes adverse events such as unplanned hospitalizations for any cause that last more than 24 hours(One Week)